The most robust clinical evidence arguably originates from the large cardiovascular outcomes trials (CVOTs) completed for most GLP-1 RAs, of which the latest showed a significant relative risk reduction (RRR) of 39% (HR) with once-weekly efpeglenatide on HF requiring hospitalisation, corroborating a meta-analysis which found a significant RRR across eight GLP-1 RA CVOTs of 11%
Antiobesity medication use among overweight and obese adults in the United States: 2015-2018
What actually predicts keeping the weight off is whether the lifestyle changes stick
GLP-1 medications promote weight loss in part by making you feel full faster
You know theres another unexpected first no one warns you about: the post-C-section hanging belly
While there have been several other weight loss medications, programs, diets, and surgical procedures available, some people still struggle with their weight with no help from these available sources